Skip to main content
. 2019 Apr 5;10(27):2644–2656. doi: 10.18632/oncotarget.26804

Table 4. LN metastasis signature score > 4 was more common in N1 vs. N0 patients (p=0.002) among the validation cohort of PDAC patients (n=54).

LN metastasis
0 1 Total
LN metastasis signature 0 Count 12 7 19
 Score>4 % within LN metastasis signature score>4 63.2% 36.8% 100%
1 Count 5 30 36
% within LN metastasis signature score>4 14.3% 85.7% 100%
Total Count 17 37 54
% within LN metastasis signature score>4 31.5% 68.5% 100%